Search hospitals > California > Loma Linda

Loma Linda University Children's Hospital

Claim this profile
Loma Linda, California 92354
Conducts research for Premature Birth
Conducts research for Respiratory Distress Syndrome
Conducts research for Acute Respiratory Distress Syndrome
Conducts research for Gut-Brain Axis Disorders
Conducts research for Stroke
21 reported clinical trials
4 medical researchers
Photo of Loma Linda University Children's Hospital in Loma LindaPhoto of Loma Linda University Children's Hospital in Loma LindaPhoto of Loma Linda University Children's Hospital in Loma Linda

Summary

Loma Linda University Children's Hospital is a medical facility located in Loma Linda, California. This center is recognized for care of Premature Birth, Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome, Gut-Brain Axis Disorders, Stroke and other specialties. Loma Linda University Children's Hospital is involved with conducting 21 clinical trials across 71 conditions. There are 4 research doctors associated with this hospital, such as Cheryl P Sanchez-Kazi, MD, Ruofan Yao, MD, MPH, Ciprian P Georghe, MD, and Gregory Aaen, MD.

Top PIs

Clinical Trials running at Loma Linda University Children's Hospital

Focal Segmental Glomerulosclerosis
Acute Lymphoblastic Leukemia
Bacterial Vaginosis
Premature Birth
T-Cell Lymphoblastic Leukemia
Lymphoma
Lymphoid Hematopoietic Disease
Acute T-Cell Leukemia
Adult T-Cell Leukemia/Lymphoma
Vaginal Infections
Image of trial facility.

LIPOSORBER® LA-15 System

for Focal Segmental Glomerulosclerosis

This trial tests a blood-filtering device called the LIPOSORBER® LA-15 System in adults with kidney issues from FSGS who haven't had success with other treatments or have had severe side effects. The device helps by cleaning the blood to protect the kidneys.
Recruiting1 award N/A2 criteria
Image of trial facility.

Liposorber LA-15 Therapy

for Focal Segmental Glomerulosclerosis

Liposorber® LA-15 System is a blood purification therapy that selectively removes malignant lipoproteins including low density lipoprotein from circulating blood flow and rapidly reduces the plasma cholesterol level. The system was originally developed for the treatment of patients with serious dyslipidemia such as familial hypercholesterolemia and then applied to improve the dyslipidemia, a common complication of nephrotic syndrome and found to bring about improvement not only with the dyslipidemic condition but the nephrotic condition (e.g, proteinuria and hypoproteinemia). Although the definitive mechanism by which the system may relieve nephrotic syndrome is unknown, it has been recognized as one of alternative therapies for refractory nephrotic syndrome including focal segmental glomerulosclerosis (FSGS) in Japan and referred in the Guidelines for the Treatment of Nephrotic Syndrome endorsed by The Japanese Society of Nephrology. This study is conducted as a post approval study imposed by Humanitarian Device Exemption (HDE) order to confirm the safety and efficacy of the Liposorber® LA-15 System in the treatment of drug-resistant pediatric primary FSGS.
Recruiting1 award N/A5 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Loma Linda University Children's Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security